Breakthrough Business Models

Drug Development for Rare and Neglected Diseases and Individualized Therapies: Workshop Summary

AvTheresa Wizemann,Sally Robinson

E-bok
Engelska, 2009

668 kr

Läs direkt i Bokus Reader – eller ladda ned till din enhet

Fler format och utgåvor

Beskrivning

The process for developing new drug and biologic products is extraordinarily expensive and time-consuming. Although large pharmaceutical companies may be able to afford the cost of development because they can expect a large return on investment, organizations developing drugs to treat rare and neglected diseases are unable to rely on such returns.

On June 23, 2008, the Institute of Medicine''s Forum on Drug Discovery, Development, and Translation held a public workshop, "Breakthrough Business Models: Drug Development for Rare and Neglected Diseases and Individualized Therapies," which sought to explore new and innovative strategies for developing drugs for rare and neglected diseases.

Produktinformation

Utforska kategorier

Hoppa över listan

Mer från samma författare

Immunization Safety Review

Institute of Medicine, Board on Health Promotion and Disease Prevention, Immunization Safety Review Committee, Marie C. McCormick, Theresa Wizemann, Donna A. Alamario, Kathleen Stratton

Häftad, 2004

762 kr

Breakthrough Business Models

Institute of Medicine, Board on Health Sciences Policy, and Translation Forum on Drug Discovery, Development, Robert Giffin, Sally Robinson, Theresa Wizemann

Häftad, 2009

728 kr

Public Health Emergency Medical Countermeasures Enterprise

Forum on Medical and Public Health Preparedness for Catastrophic Events, and Translation Forum on Drug Discovery, Development, Board on Health Sciences Policy, Institute of Medicine, Theresa Wizemann, Clare Stroud, Bruce M. Altevogt

E-bok
2010

544 kr

Public Health Emergency Medical Countermeasures Enterprise

Forum on Medical and Public Health Preparedness for Catastrophic Events, and Translation Forum on Drug Discovery, Development, Board on Health Sciences Policy, Institute of Medicine, Theresa Wizemann, Clare Stroud, Bruce M. Altevogt

E-bok
2010

802 kr

Value of Genetic and Genomic Technologies

Roundtable on Translating Genomic-Based Research for Health, Board on Health Sciences Policy, Institute of Medicine, Theresa Wizemann, Adam C. Berger

E-bok
2010

376 kr

Hoppa över listan

Du kanske också är intresserad av

Breakthrough Business Models

Theresa Wizemann, Sally Robinson, Robert Giffin, and Translation Forum on Drug Discovery, Development, Board on Health Sciences Policy, Institute of Medicine

E-bok
2009

468 kr

Emerging Safety Science

Institute of Medicine, Board on Health Sciences Policy, and Translation Forum on Drug Discovery, Development, Robert Giffin, Robert Pool, Sally Robinson

Häftad, 2008

668 kr

Emerging Safety Science

Sally Robinson, Robert Pool, Robert Giffin, and Translation Forum on Drug Discovery, Development, Board on Health Sciences Policy, Institute of Medicine

E-bok
2008

668 kr

Emerging Safety Science

Sally Robinson, Robert Pool, Robert Giffin, and Translation Forum on Drug Discovery, Development, Board on Health Sciences Policy, Institute of Medicine

E-bok
2008

468 kr

Breakthrough Business Models

Institute of Medicine, Board on Health Sciences Policy, and Translation Forum on Drug Discovery, Development, Robert Giffin, Sally Robinson, Theresa Wizemann

Häftad, 2009

728 kr